Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/2010
05/26/2010CN101711763A Prulifloxacin composition and preparation method thereof, and synthesis method of raw material drugs
05/26/2010CN101711762A Medicine composition for treating hypertension
05/26/2010CN101711761A Compositions for prevention and treatment of cold and influenza-like symptoms and use methods thereof.
05/26/2010CN101711760A Thiophene derivative with excellent function of blood glucose reduction and adduct PPAR alpha/gamma double agonists thereof
05/26/2010CN101711759A Application of cumarins compound in preparing medicine for inhibiting tumor growth
05/26/2010CN101711758A Application of apigenin in preparing medicament for preventing and treating diseases caused by ischemic injuries of humans
05/26/2010CN101711757A High-efficiency sterilization disinfectant and preparation method thereof
05/26/2010CN101711756A Application of 3-phenyl-3-(4-nitryl phenylamino)-1-(4-chlorphenyl)-1-acetone as non-steroidal androgen receptor regulating agent
05/26/2010CN101711755A Pressure sensitive adhesive matrix device or system for the treatment or prevention of onychomycosis or tinea pedis
05/26/2010CN101711754A Tamoxifen citrate emplastrum and preparation method thereof
05/26/2010CN101711753A Preparation method of lansoprazole solid preparation
05/26/2010CN101711752A Controlled release preparation of benzo-isoxazole derivant and preparation method thereof
05/26/2010CN101711751A Febuxostat dispersing tablet preparation and preparation method thereof
05/26/2010CN101711750A Fluconazole dispersing tablet and preparation method thereof
05/26/2010CN101711749A Nicergoline sublingual tablet and preparation method thereof
05/26/2010CN101711748A Method for preparing cefaclor dispersible tablets by dry method direct tablet compressing and cefaclor dispersible tablets prepared by same
05/26/2010CN101711747A Medicine application preparation for treating hypertension
05/26/2010CN101711746A Ganciclovir freeze-dry preparation for injection and preparation method thereof
05/26/2010CN101711745A Intraocular nano particle freeze-dried powders and preparation method thereof
05/26/2010CN101711744A Suspension powder-injection preparation of amoxicillin sodium and flucloxacillin sodium medicinal composition and new application thereof
05/26/2010CN101711743A Febuxostat dry suspension and preparation method thereof
05/26/2010CN101711742A Cefaclor submicro-emulsion solid preparation and novel application thereof
05/26/2010CN101711741A Cefixime submicro-emulsion solid preparation and novel application thereof
05/26/2010CN101711740A Method for preparing targeted curcumin nanoparticles for treating ulcerative colitis
05/26/2010CN101711739A Oral medicament combination of carbamazepine
05/26/2010CN101711738A Oral pharmaceutical composition of Fenofibrate
05/26/2010CN101711737A Agents for intravitreal administration to treat or prevent disorders of the eye
05/26/2010CN101711513A Method for increasing sow ovulation rate and injection thereof
05/26/2010CN101314042B Water-soluble 4'-nor-epipodophyllotoxin derivant and preparation method thereof
05/26/2010CN101273991B Applications of tetrahydroindolone/tetrahydroindazolone/tetrahydrocarbazole derivatives and salts thereof in preparation of antiviral medicine
05/26/2010CN101190895B N-[(3S)-1,2,3,4-tetrahydroisoquinolino-3-formacyl]amino acid, preparation method and application thereof
05/26/2010CN101164551B Optimized formula for liver cancer-resisting traditional Chinese medicine active ingredient
05/26/2010CN101161241B Technique of preparing amlodipine besylate tablets
05/26/2010CN101152184B Diclazuril effervescence patch for birds
05/26/2010CN101152163B Anti-cicatrix externally used pad pasting containing hormone medicament and method for preparing the same
05/26/2010CN101112383B Compositions for treating of cough
05/26/2010CN101111477B Benzoyl-tetrahydropyridine as glyt-1 inhibitors
05/26/2010CN101104618B Long chain alkyl berberine salt derivative, synthetic method and use
05/26/2010CN101099854B External-applied traditional Chinese medicine preparation for treating rheumatism pain disease and preparing method
05/26/2010CN101099762B Blood pressue lowering sustained-release preparation with chrysanthemum flower and pearl
05/26/2010CN101095688B Application of mannose in the preparation of medicine for treating pulmonary inflammation disease
05/26/2010CN101068779B 9,10-secopregnane derivative and medicine
05/26/2010CN101066258B Inclusion compound of higher fatty alcohol and its preparation
05/26/2010CN101062114B Method for distilling flavone from tartary buckwheat bran
05/26/2010CN101058595B Ibonucleic acid, and preparation method and application thereof
05/26/2010CN101058564B Aryl alkyl carbamate derivatives production and use thereof in therapy
05/26/2010CN101058543B Process for producing amine derivatives
05/26/2010CN101050170B New type natural active compound for anti tumor, preparation method, and application
05/26/2010CN101045051B Novel use of tizanidine or its derivatives in preparing medicine for prolonging fast wave sleep
05/26/2010CN101040860B Pharmaceutical composition for treatment of lower urinary tract diseases
05/26/2010CN101040847B Nanometer medicine agent produced by hydrogenated castor oil and the technique of preparing the same
05/26/2010CN101032614B Chinese traditional composition for curing slow concrescence or non-concrescence of fracture and the preparing method
05/26/2010CN101032505B Treatment medicine and healthy product including liquiritin
05/26/2010CN101032504B Application of liquiritin in medicines
05/26/2010CN101032484B Capsule type tiotropium bromide inhalation powder
05/26/2010CN101031589B Spray composition having a deposition control agent
05/26/2010CN101031540B Hexafluoroisopropanol substituted ether derivatives
05/26/2010CN101028281B Nano-gel pectin bismuth and its granules medicine
05/26/2010CN101019814B Application of non-depolarizing muscular relaxant in preventing and eliminating facial wrinkles
05/26/2010CN101015648B Use of succinic acid derivative eater compound for treating dementia
05/26/2010CN101001543B Lipoic acid concentrate
05/26/2010CA2645749A1 Soy kefir powder and uses thereof
05/25/2010USRE41356 Hepatitis C inhibitor tri-peptides
05/25/2010US7724943 Rapid and robust 3D/3D registration technique
05/25/2010US7723537 Skin lightening agents, compositions and methods
05/25/2010US7723532 Pharmaceutical compositions 3
05/25/2010US7723527 Benzoimidazole compounds
05/25/2010US7723526 Benzoimidazole compounds
05/25/2010US7723524 8-cyanoquinolonecarboxylic acid derivative
05/25/2010US7723523 Tetrahydropyridothiophenes
05/25/2010US7723519 high binding efficiencies between D3 and D2 dopaminergic receptor subtypes; drug abuse, drug dependence
05/25/2010US7723515 Methylene blue—curcumin analog for the treatment of alzheimer's disease
05/25/2010US7723513 Methods and intermediates for the synthesis of dipyrrin-substituted porphyrinic macrocycles
05/25/2010US7723509 Conjugated lipophilic group with a modified nucleotide is used to target disease gene, cells, tissue, for drug delivery to target tumor cells; ribose sugar of nucleotide is replaced with a cyclic carrier which has at least one attached phosphate or phosphorothioate group; biodrugs
05/25/2010US7723503 nucleotide sequences or complements that encode polypeptides having omega-3 desaturase and delta-12 desaturase enzyme activity, used for making polyunsaturated fatty acids; additives for drugs, nutritional compositions, animal feeds, as well as other products such as cosmetics
05/25/2010US7723500 Containing unmethylated CpG dinucleotides; redirection of a Th2 response to a Th1 response; atopic diseases, dermatitis; booster vaccines
05/25/2010US7723499 polynucleotides that code for polypeptides comprising amino acid sequences that preferentially recognize and bind to angiopoietins
05/25/2010US7723496 Tumor antigen for diagnosis and treatment of cell proliferative disorders
05/25/2010US7723392 Use of RR/SR-ractopamine
05/25/2010US7723391 N-(1,1-dialkyl-2-arylcyclopropyl)arylcarboxamides, e.g., Chloro-N-[cis-2,2-dimethyl-3-(4-sulfamoyl-phenyl)-cyclopropyl]-2-methoxy-benzamide; nicotinic acetylcholine receptor ligands, particularly positive allosteric modulators for the alpha 7 nAChR subtype
05/25/2010US7723390 Thyroid hormones or their salts in capsule or in swallowable uniform soft-gel gelatin matrices for treatment of hypothyroidism
05/25/2010US7723389 N-acetylcysteine compositions and methods for the treatment and prevention of drug toxicity
05/25/2010US7723388 secretions is derived from around the uropygial gland of an avian; attractants for treating bird weight loss, during transportation to eliminate their tension; animal extracts for treating bird's behavioral disorder, nervous system disorder
05/25/2010US7723387 Self-neutralizing acid peel for dermatologic use
05/25/2010US7723386 foods containing triglycerides where polyunsaturated fatty acid is bonded to 2-position of triglyceride
05/25/2010US7723385 Aniline derivatives as selective androgen receptor modulators
05/25/2010US7723384 1H-2-Benzazepine-1,5(2H)-dione derivatives in which the N is connected via alkylene to a saturated or monounsaterated nitrogen heterocycle, e.g.,2-(3-{4-[2-tert-Butyl-6-(trifluoromethyl)pyrimidin-4-yl]piperazin-1-yl}propyl)-3,4-dihydro-1H-2-benzazepine-1,5(2H)-dione; dopamine-3 receptor modulators
05/25/2010US7723383 Therapeutic agents for treating acne
05/25/2010US7723382 Process for preparing nitrooxyalkyl substituted esters of carboxylic acids, intermediates useful in said process and preparation thereof
05/25/2010US7723381 Compounds for the treatment of inflammatory diseases
05/25/2010US7723380 Tetrahydrofuro[2,3-b]furyl carbamates containing an (oxy)hydrazide group; these compounds target the HIV protease in both wild type and mutant strains of HIV.
05/25/2010US7723379 Dosage form of polysaccharides, especially cocoa extracts, containing procyanidine units an additional nitric oxide modulating agent; dietary supplements; pet foods
05/25/2010US7723378 G protein-coupled receptor S1P1/EDG1 agonists; 3-(4-hydroxy-3,5-dimethyl-phenyl)-1-(3,5,5-trimethyl-4,5,6,7-tetrahydro-benzo[c]thiophen-1-yl)-propan-1-one; transplant rejection, graft-versus-host diseases, autoimmune syndromes; side effects reduction; immunosuppressive agents; Crohn's disease
05/25/2010US7723377 Inhibitors of cognitive decline
05/25/2010US7723376 Alkanoic acids, amides and N-oxyamides omega-substituted with an N-substituted 2,5-dihydro-1H-pyrrol-3-yl- group are histone deacetylase inhibitors; treating prostate cancer
05/25/2010US7723375 Metabolites of wortmannin analogs and methods of using the same
05/25/2010US7723374 3-[5-ethoxy-1-(4-ethyl-benzenesulfonyl)-1H-indol-3-yl]-propionic acid for example; obesity, diabetes, syndrome X, breast or thyroid cancer, inflammatory skin disorders such as psoriasis, cardiovascular disorders, eating disorders such as bulimia; peroxisome proliferator-activated receptors (PPAR) agonist
05/25/2010US7723373 3-(Aryl or heteroaryl)sulfonyl- or sulfinyl-1-indoleacetic acid derivatives, e.g., 3 -[(4-chlorophenyl)sulfonyl]-2,5-dimethyl-1H-indol-1-acetic acid; treating asthma, rhinitis and other diseases in which raised levels of PGD2 or its metabolites
05/25/2010US7723372 Spiro[2-cyclohexene-1,3'-[3H]indole]-2',4(1'H)-diones and 4-hydroxyspiro[2-cyclohexene-1,3'-[3H]indol]-2'(1'H)-ones; act as antagonists of mdm2 interactions; useful as potent and selective anticancer agents
05/25/2010US7723370 P-3-(trifluoromethyl)-5-(p-tolyl)pyrazol-1-yl)benzenesulonylaminooxy- compounds; more effective than celecoxib and have fewer gastrointestinal and cardiovascular side effects; 4-(5-p-methyl-phenyl)-3-trifluoromethyl-pyrazol-1-yl)-benzenesulfonic acid intermediate
1 ... 2256 2257 2258 2259 2260 2261 2262 2263 2264 2265 2266 2267 2268 2269 2270 2271 2272 2273 2274 2275 2276 ... 7860